8-22046282-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003867.4(FGF17):āc.241A>Gā(p.Asn81Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000308 in 1,461,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003867.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF17 | NM_003867.4 | c.241A>G | p.Asn81Asp | missense_variant | 3/5 | ENST00000359441.4 | NP_003858.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF17 | ENST00000359441.4 | c.241A>G | p.Asn81Asp | missense_variant | 3/5 | 1 | NM_003867.4 | ENSP00000352414.3 | ||
FGF17 | ENST00000518533.5 | c.208A>G | p.Asn70Asp | missense_variant | 3/5 | 1 | ENSP00000431041.1 | |||
FGF17 | ENST00000521709.1 | n.586A>G | non_coding_transcript_exon_variant | 2/3 | 3 | |||||
FGF17 | ENST00000524314.1 | n.1611A>G | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250374Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135482
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461132Hom.: 0 Cov.: 33 AF XY: 0.0000234 AC XY: 17AN XY: 726814
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2023 | The c.241A>G (p.N81D) alteration is located in exon 3 (coding exon 3) of the FGF17 gene. This alteration results from a A to G substitution at nucleotide position 241, causing the asparagine (N) at amino acid position 81 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at